Online Program

333342
Terms of engagement: Researching the delivery of public health services by community pharmacies in England


Tuesday, November 3, 2015 : 10:50 a.m. - 11:10 a.m.

Karen Hassell, PhD, College of Pharmacy, California Northstate University, Elk Grove, CA
Sally Jacobs, PhD, Manchester Pharmacy School, University of Manchester, UK, Manchester, United Kingdom
Ellen Schafheutle, PhD, Manchester Pharmacy School, University of Manchester, UK, Manchester, United Kingdom
Devina Halsall, PhD, Manchester Pharmacy School, University of Manchester, UK, Manchester, United Kingdom
Fay Bradley, PhD, Manchester Pharmacy School, University of Manchester, UK, Manchester, United Kingdom
Rebecca Elvey, PhD, Institute for Population Health, Centre for Primary Care, University of Manchester, UK, Manchester, United Kingdom
Tom Fegan, MPharm, Manchester Pharmacy School, University of Manchester, UK, Manchester, United Kingdom
Mark Hann, PhD, Institute for Population Health, Centre for Biostatistics, University of Manchester, UK, Manchester, United Kingdom
Andrew Wagner, MSc, Division 5, NIHR Comprehensive Research Network Eastern, Cambridge, United Kingdom
Background: Engaging community pharmacies in research providing evidence of their contribution to public health is not easy. An experienced team of researchers from a pharmacy school in England were funded by a national government agency to explore variation in clinical productivity in community pharmacies. The study involved a survey of community pharmacies, analysis of activity data, a patient survey and stakeholder interviews. Aim: To explain the public health context against which the study was undertaken, share our strategies for achieving engagement, and highlight what success looks like. Method:  Strategies for engagement included: meetings with key stakeholders prior to study design to ground the study design in the practice context; setting up an advisory group including pharmacy, service commissioner and patient representatives to provide advice throughout the study; presentations to national and local pharmacy organizations to invite endorsement of the study; individual approaches to organizational gatekeepers to clarify the purpose and benefits of the study, and secure agreement to participate. Results:  This study encountered reactions ranging from enthusiasm and encouragement to deep mistrust and negativity, stemming partly from commercial sensitivities. Early engagement was vital but not always successful. Non-participation necessitated changes in study design, and response rate to the pharmacy survey was low.  Recruitment to latter stages of the study was enhanced through established relationships and earlier lessons learned. Discussion:  Understanding the political and commercial landscape in which community pharmacy operates is key to success; early engagement and personal meetings with pharmacy stakeholders were crucial for creating rapport and trust.

Learning Areas:

Other professions or practice related to public health
Provision of health care to the public
Public health administration or related administration
Public health or related organizational policy, standards, or other guidelines
Public health or related public policy
Public health or related research

Learning Objectives:
Describe the organization and delivery of public health services by community pharmacy services in England Discuss some of the barriers to conducting public health research in English community pharmacies Identify some solutions to engaging pharmacies in the research process

Keyword(s): Pharmacists, Health Care Delivery

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I have been the principal or co-investigator of multiple UK government, regulatory body and charity-funded grants focusing on the organization and delivery of community pharmacy medicines-related healthcare and public health services, specializing in workforce issues.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.